StockWatch
·
Biotechnology: Pharmaceutical Preparations
SplitAug 5, 2026, 08:05 AM

Jupiter Neurosciences Announces 1-for-75 Reverse Stock Split

AI Summary

Jupiter Neurosciences, Inc. announced a 1-for-75 reverse stock split, approved by stockholders on July 22, 2026, and effective August 6, 2026. The split aims to increase the per share trading price to regain compliance with Nasdaq's minimum bid price requirement for continued listing. Trading on a split-adjusted basis will begin on August 7, 2026, under the current ticker JUNS and a new CUSIP number. The reverse split will reduce the number of outstanding shares from approximately 57.76 million to about 0.77 million, with cash payments for fractional shares.

Key Highlights

  • Board of directors approved a 1-for-75 reverse stock split.
  • The reverse split will be legally effective on August 6, 2026, at 4:01 p.m. ET.
  • Post-split adjusted trading will commence on August 7, 2026, under the current ticker JUNS.
  • The split aims to regain compliance with Nasdaq's minimum bid price requirement.
  • Outstanding common stock will decrease from approximately 57.76 million to 0.77 million shares.
  • Stockholders will receive cash in lieu of fractional shares.
  • A new CUSIP number, 48208B 302, will be assigned for the common stock.